Breaking News Instant updates and real-time market news.

ARDX

Ardelyx

$13.25

0.6 (4.74%)

07:04
10/19/16
10/19
07:04
10/19/16
07:04

Ardelyx's tenapanor for IBS-C presents positive global endpoint data

Ardelyx presentated positive global endpoint data from its Phase 2b trial, completed in September 2014, which evaluated tenapanor for the treatment of patients with irritable bowel syndrome with constipation. The company is also evaluating tenapanor in a Phase 3 study for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis, with data expected to be reported in 1Q17. The IBS symptom global endpoints in the Phase 2b study included: adequate IBS symptom relief; improvements in IBS severity, constipation severity and treatment satisfaction. Compared to placebo, treatment with 50 mg of tenapanor twice a day resulted in statistically significant improvements in all global endpoints measured. 63.1% of patients treated with 50 mg of tenapanor twice a day reported adequate relief of IBS symptoms compared to 39.3% for patients on placebo.

ARDX Ardelyx
$13.25

0.6 (4.74%)

03/09/16
03/09/16
INITIATION

On The Fly: Top Five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MSG Networks (MSGN) initiated with an Underperform at CLSA by analyst Vasily Karasyov, who expects shares to be range bound given topline pressures from expected subscriber leakage from tiering and proliferation of skinny budgets. 2. FANUC (FANUY) initiated with an Outperform at Bernstein citing the company's technologies and manufacturing capabilities. 3. Ardelyx (ARDX) initiated with a Buy at Cantor. 4. Determine (DTRM) initiated with a Buy at Maxim. 5. Platform Specialty Products (PAH) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/16
SBSH
03/29/16
NO CHANGE
SBSH
Citi lays out potential targets for next biotech M&A wave
Citi analyst Yigal Nochomovitz believes the setup for the next acquisition cycle in the biotech space is here, but that biotech management's desire to do deals is the missing catalyst. He thinks another one-to-three quarters is needed before "reset valuations are better absorbed as the new reality." Large cap pharma and biotech companies are cash rich and have signaled repeatedly over last year that they are looking for new assets, Nochomovitz tells investors in a research note. He sees a "greater probability" of a takeover over the next 12-18 months for Ardelyx (ARDX), Medivation (MDVN), Ophthotech (OPHT), Puma Biotechnology (PBYI), Portola Pharmaceuticals (PTLA), Ultragenyx (RARE), Relypsa (RLYP) and Versartis (VSAR). He sees a "moderate probability" of a takeover for Anthera (ANTH), Loxo Oncology (LOXO), MacroGenics (MGNX) and Mirati Therapeutics (MRTX). Nochomovitz also sees a "lower probability" of a buyout for Atara Biotherapeutics (ATRA), Chimerix (CMRX), Keryx (KERX) and Mirna Therapeutics (MIRN).
03/31/16
LTCO
03/31/16
INITIATION
Target $21
LTCO
Buy
Ardelyx initiated with a Buy at Ladenburg
Ladenburg analyst Matt Kaplan started Ardelyx with a Buy rating and $21 price target.
04/08/16
SBSH
04/08/16
NO CHANGE
SBSH
Citi lays out potential targets after break of Pfizer, Allergan deal
Citi analysts Yigal Nochomovitz, Liav Abraham and Joel Beatty argue that the break of the Pfizer (PFE), Allergan (AGN) merger could accelerate smaller scale acquisitions in the Biotechnology sector. The implication that larger companies could accelerate M&A activity to bolster pipelines in lieu of the mega-merger pathway aided shares in the sector this week, the analysts contend in a research note. They now believe that Ardelyx (ARDX), Medivation (MDVN), Ophthotech (OPHT), Puma Biotechnology (PBYI), Portola Pharmaceuticals (PTLA), Ultragenyx (RARE), Relypsa (RLYP) and Versartis (VSAR) have a greater probability of being acquired in the next 12-18 months. Beside these favored names for a takeover, analyst Joel Beatty sees a greater chance of Catabasis Pharmaceuticals (CATB), Intercept Pharmaceuticals (ICPT), Novavax (NVAX) and Raptor Pharmaceuticals (RPTP) getting acquired over the next 18 months.

TODAY'S FREE FLY STORIES

NUVA

NuVasive

$75.54

-1.15 (-1.50%)

08:08
06/28/17
06/28
08:08
06/28/17
08:08
Recommendations
NuVasive analyst commentary  »

NuVasive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 15

    Aug

CA

CA Technologies

$34.62

-0.19 (-0.55%)

08:08
06/28/17
06/28
08:08
06/28/17
08:08
Recommendations
CA Technologies analyst commentary  »

Potential CA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$60.84

-0.32 (-0.52%)

08:06
06/28/17
06/28
08:06
06/28/17
08:06
Initiation
XPO Logistics initiated  »

XPO Logistics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:06
06/28/17
06/28
08:06
06/28/17
08:06
Earnings
Breaking Earnings news story on Monsanto »

Monsanto reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MON

Monsanto

$117.25

-0.55 (-0.47%)

08:05
06/28/17
06/28
08:05
06/28/17
08:05
Earnings
Monsanto reports Q3 EPS $1.90, consensus $1.76 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CBI

CB&I

$20.03

5.63 (39.10%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
CB&I awarded contract by Shurtan Gas Chemical Complex »

CB&I announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMNX

Luminex

$20.92

-0.3 (-1.41%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
Luminex receives CE-IVD mark for ARIES Norovirus Assay »

Luminex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

NVIV

InVivo Therapeutics

$2.75

0.2 (7.84%)

08:04
06/28/17
06/28
08:04
06/28/17
08:04
Hot Stocks
InVivo Therapeutics reports two patients in study improve in INSPIRE assessments »

InVivo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MSA

MSA Safety

$79.73

0.44 (0.55%)

08:03
06/28/17
06/28
08:03
06/28/17
08:03
Hot Stocks
MSA Safety to acquire Globe Holding Company for $215M in cash »

MSA Safety announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Holdings

$86.01

-0.61 (-0.70%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Initiation
HCA Holdings initiated  »

HCA Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$87.90

0.08 (0.09%)

07:59
06/28/17
06/28
07:59
06/28/17
07:59
Upgrade
State Street rating change  »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

OLN

Olin Corp.

$29.31

0.29 (1.00%)

07:58
06/28/17
06/28
07:58
06/28/17
07:58
Recommendations
Olin Corp. analyst commentary  »

Cowen calls Olin Corp. a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$10.40

0.09 (0.87%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
Daseke analyst commentary  »

Daseke revenue synergies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRU

TransUnion

$43.52

-0.78 (-1.76%)

07:57
06/28/17
06/28
07:57
06/28/17
07:57
Recommendations
TransUnion analyst commentary  »

TransUnion guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

COST

Costco

$159.26

-0.94 (-0.59%)

, AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

07:56
06/28/17
06/28
07:56
06/28/17
07:56
Recommendations
Costco, Amazon.com analyst commentary  »

Costco weakness a buying…

COST

Costco

$159.26

-0.94 (-0.59%)

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 23

    Aug

PYPL

PayPal

$52.73

-1.01 (-1.88%)

07:55
06/28/17
06/28
07:55
06/28/17
07:55
Recommendations
PayPal analyst commentary  »

PayPal shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

07:55
06/28/17
06/28
07:55
06/28/17
07:55
General news
N.Y. FX Outlook »

N.Y. FX Outlook: The…

BSX

Boston Scientific

$27.81

0.09 (0.32%)

07:53
06/28/17
06/28
07:53
06/28/17
07:53
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ADMA

ADMA Biologics

$4.06

0.46 (12.78%)

07:50
06/28/17
06/28
07:50
06/28/17
07:50
Recommendations
ADMA Biologics analyst commentary  »

Biotest deal gives ADMA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CKH

Seacor

$32.49

0.19 (0.59%)

07:49
06/28/17
06/28
07:49
06/28/17
07:49
Recommendations
Seacor analyst commentary  »

Seacor divestment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUSA

Murphy USA

$72.01

-0.44 (-0.61%)

07:48
06/28/17
06/28
07:48
06/28/17
07:48
Recommendations
Murphy USA analyst commentary  »

Murphy USA a top pick for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$6.14

-0.16 (-2.54%)

07:48
06/28/17
06/28
07:48
06/28/17
07:48
Hot Stocks
Ziopharm initiates stereotactic arm of Ad-RTS-hIL-12 + veledimex Phase 1 study »

Ziopharm announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVA

Sinovac Biotech

$6.34

-0.07 (-1.09%)

07:46
06/28/17
06/28
07:46
06/28/17
07:46
Hot Stocks
Sinobioway proposes $8 per share takeover of Sinovac Biotech »

The Shandong Sinobioway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$19.11

0.57 (3.07%)

07:46
06/28/17
06/28
07:46
06/28/17
07:46
Hot Stocks
Universal Stainless & Alloy reaches early labor agreement at Dunkirk facility »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$11.35

-0.12 (-1.05%)

07:45
06/28/17
06/28
07:45
06/28/17
07:45
Hot Stocks
Kratos Defense awarded UAV contract amendment by U.S. Navy »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.